Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Surgical Pathology

• Publication date

  2003-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000478-200305000-00005PMID 12717246
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sarcomatoid differentiation in renal cell carcinoma: prognostic implications.

  2005cited by this paper
• Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients.

  2002cited by this paper
• Collecting duct renal cell carcinoma: clinical study of a rare tumor.

  2002cited by this paper
• Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.

  2002cited by this paper
• Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.

  2002cited by this paper
• Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms: An Experience of 405 Cases

  2002cited by this paper
• Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival.

  2001cited by this paper
• Sarcomatoid Differentiation in Renal Cell Carcinoma: A Study of 101 Cases

  2001cited by this paper
• Chromophobe renal cell carcinoma: Clinical, pathological and molecular biological aspects

  2000cited by this paper
• Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma

  2000influential reference
• Diagnosis and classification of renal cell carcinoma.

  1999cited by this paper
• Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients

  1999cited by this paper
• Prognostic Significance of the Heidelberg Classification of Renal Cell Carcinoma

  1999influential reference
• Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases.

  1999cited by this paper
• Collecting duct carcinoma of kidney.

  1998cited by this paper
• Classification of renal cell carcinoma

  1997cited by this paper
• The Heidelberg classification of renal cell tumours

  1997cited by this paper
• Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

  1997cited by this paper
• Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

  1997cited by this paper
• Sarcomatoid renal cell carcinoma: the chromophobe connection.

  1997cited by this paper
• THE HEIDELBERG CLASSIFICATION OF RENAL CELL TUMOURS

  1997influential reference
• Chromophobe cell renal carcinoma: clinicopathological features of 50 cases.

  1995cited by this paper

• Noninvasive renal mass diagnostic models based on radiomic features and clinical data: a multi-center study.

  2026cites this paper
• Deep Learning Identification of Clear Cell Renal Cell Carcinoma on MR Imaging.

  2026cites this paper
• A comprehensive multi-task deep learning model for kidney cancer: histological subtyping, clinical staging, and anatomical complexity grading.

  2026cites this paper
• Lomitapide reduces viability and clonogenicity in hepatocellular carcinoma cells but enhances xenograft growth: The importance of the tumor microenvironment.

  2026cites this paper
• A retrospective analysis of multiparametric ultrasound features in chromophobe renal cell carcinoma

  2025cites this paper
• State of the art review of AI in renal imaging

  2025cites this paper
• Outcomes of anticoagulation treatment for renal cell carcinoma tumour thrombi: a systematic review.

  2025cites this paper
• Dual-domain contrastive learning for three-dimensional multi-parametric magnetic resonance imaging to end-to-end predict kidney cancer subtypes

  2025cites this paper
• Prognostic impact of non-clear cell histology on recurrence and cancer-free survival in renal cell carcinoma: a time-to-event analysis

  2025cites this paper
• Case Report: Locally advanced clear cell renal cell carcinoma with pathological complete response following nephrectomy and thrombectomy after nivolumab and cabozantinib treatment

  2025cites this paper
• Clinicohistopathological characteristics of renal cell carcinoma in Jordan

  2025cites this paper
• New Approaches in Nuclear Medicine Theranostics.

  2025cites this paper
• Computed tomography-based delta-radiomics analysis for preoperative prediction of ISUP pathological nuclear grading in clear cell renal cell carcinoma

  2025cites this paper
• Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy

  2025cites this paper
• Prediction of Distant Metastasis of Renal Cell Carcinoma Based on Interpretable Machine Learning: A Multicenter Retrospective Study

  2025cites this paper
• A Review of Immunotherapy in Renal Cell Carcinoma: Current Landscape and Future Directions

  2025cites this paper
• pVHL status in clear cell renal cell carcinoma regulates HIF-α and E-cadherin expression levels and their implications for tumor progression

  2025influential citation
• A rare case of late chromophobe RCC metastasis with indolent course

  2025cites this paper
• From Radiomics to Radiogenomics: Decoding Renal Cell Carcinoma Biology for Precision Medicine—a narrative review

  2025cites this paper
• Neue Ansätze in der Nuklearmedizinischen Diagnostik und Therapie

  2025cites this paper
• Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1)

  2025cites this paper
• Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes.

  2025cites this paper
• Racial Differences in Survival for Locally Advanced Renal Cell Carcinoma.

  2025cites this paper
• Synchronous coexistence of type 1 papillary renal cell carcinoma and primary mucinous adenocarcinoma of the pelvicalyceal system in single kidney

  2025cites this paper
• Applicability of the regression approach for histological multi-class grading in clear cell renal cell carcinoma

  2025cites this paper
• Clinicopathological Profile and Treatment Outcome of Renal Cell Carcinoma: A Review from a Tertiary Cancer Centre in North East India

  2025cites this paper
• Expression of HIF‑α and their association with clinicopathological parameters in clinical renal cell carcinoma

  2024cites this paper
• Matrix- and Surface-Assisted Laser Desorption/Ionization Mass Spectrometry Methods for Urological Cancer Biomarker Discovery—Metabolomics and Lipidomics Approaches

  2024cites this paper
• The role of lncRNA HCG18 in human diseases

  2024cites this paper
• Understanding Factors that Influence Prognosis and Response to Therapy in Clear Cell Renal Cell Carcinoma.

  2024cites this paper
• A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma

  2024cites this paper
• Integration of basement membrane-related genes in a risk signature for prognosis in clear cell renal cell carcinoma

  2024cites this paper
• An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma– results from a nation-wide study covering 50 years in Iceland

  2024cites this paper
• Clinical T1/2 renal cell carcinoma: multiparametric dynamic contrast-enhanced MRI features-based model for the prediction of individual adverse pathology

  2024cites this paper
• Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches

  2024cites this paper
• A systematic investigation of clear cell renal cell carcinoma using meta-analysis and systems biology approaches

  2024cites this paper
• Application value of contrast-enhanced ultrasound in the preoperative evaluation of renal cell carcinoma histological classification and RENAL score

  2024cites this paper
• UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120)

  2024influential citation
• KidneyNet: A Novel CNN-Based Technique for the Automated Diagnosis of Chronic Kidney Diseases from CT Scans

  2024cites this paper
• Comparative Proteomics of ccRCC Cell Lines to Identify Kidney Cancer Progression Factors

  2024cites this paper
• Primary tumor characteristics and immunohistochemical profile of renal cell carcinoma in serous fluid cytology.

  2024cites this paper
• Histomorphological Study of Nephrectomy Specimens with Assessment of Prognostic Parameters in Renal Cell Carcinoma

  2024cites this paper
• Survival analysis of clear cell renal cell carcinoma based on radiomics and deep learning features from CT images

  2024cites this paper
• Cytotoxic T lymphocyte associated antigen-4 (CTLA4) expression with renal cell carcinoma subtype and staging

  2024cites this paper
• Detection of two synchronous histologically different renal cell carcinoma subtypes in the same kidney: a case report and review of the literature

  2024cites this paper
• Acetylation- and ubiquitination-regulated SFMBT2 acts as a tumor suppressor in clear cell renal cell carcinoma

  2024cites this paper
• Development of prognostic signatures and risk index related to lipid metabolism in ccRCC

  2024cites this paper
• Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma

  2024cites this paper
• To characterize small renal cell carcinoma using diffusion relaxation correlation spectroscopic imaging and apparent diffusion coefficient based histogram analysis: a preliminary study

  2024cites this paper
• Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma.

  2024cites this paper
• Artificial Intelligence-Based Non-invasive Differentiation of Distinct Histologic Subtypes of Renal Tumors With Multiphasic Multidetector Computed Tomography

  2024cites this paper
• Transarterial ethiodised oil marking before CT-guided renal cryoablation: evaluation of tumour visibility in various renal cell carcinoma subtypes.

  2023cites this paper
• Survival prediction in renal cell carcinoma patients using machine learning

  2023cites this paper
• Exploring Renal Malignancies in Saudi Arabia: Insights from a Tertiary Care Center Study

  2023cites this paper
• Chromophobe renal cell carcinoma with massive sarcomatoid differentiation

  2023cites this paper
• Automated Small Kidney Cancer Detection in Non-Contrast Computed Tomography

  2023cites this paper
• Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma

  2023cites this paper
• Genetic profiling uncovers genome-wide loss of heterozygosity and provides insight in carcinogenesis of sarcomatoid transformation of chromophobe renal cell carcinoma.

  2023cites this paper
• Multi-phase-combined CECT radiomics models for Fuhrman grade prediction of clear cell renal cell carcinoma

  2023cites this paper
• Prognostic factors in renal cell carcinoma: A single‑center study

  2023influential citation
• Tyrosine kinase and immune checkpoints inhibitors in favorable risk metastatic renal cell carcinoma: Trick or treat?

  2023cites this paper
• Surgical Management and Oncologic Outcomes of Renal Cell Carcinoma and Inferior Vena Caval Thrombi with Aggressive Histologic Variants.

  2023cites this paper
• Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review

  2023cites this paper
• Role of AI and Radiomic Markers in Early Diagnosis of Renal Cancer and Clinical Outcome Prediction: A Brief Review

  2023cites this paper
• Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings

  2023cites this paper
• Oncological outcomes of papillary versus clear cell renal cell carcinoma in pT1 and pT2 stage: Results from a contemporary Turkish patient cohort.

  2023cites this paper
• Imaging Recommendations for Diagnosis, Staging, and Management of Renal Tumors

  2023cites this paper
• Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network

  2023cites this paper
• Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism.

  2023cites this paper
• Multiparametric magnetic resonance imaging for characterizing renal tumors: A validation study of the algorithm presented by Cornelis et al.

  2023cites this paper
• Quantification of structural heterogeneity in H&E stained clear cell renal cell carcinoma using refractive index tomography.

  2023cites this paper
• New insights into fibrotic signaling in renal cell carcinoma

  2023cites this paper
• Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)

  2023cites this paper
• Comparison and validation of different risk models for papillary renal cell carcinoma.

  2023cites this paper
• Magnetic Resonance Imaging Virtual Biopsy of Common Solid Renal Masses—A Pictorial Review

  2023cites this paper
• Clinical pathological characteristics and treatment outcomes of renal cell carcinoma (RCC): a retrospective study from Sudan

  2023cites this paper
• Exploring the role of natural bioactive molecules in genitourinary cancers: how far has research progressed?

  2023cites this paper
• Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation

  2023influential citation
• Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma

  2022cites this paper
• Grading of clear cell renal cell carcinoma using diffusion MRI with a fractional order calculus model

  2022cites this paper
• piRNAs and PIWI Proteins as Diagnostic and Prognostic Markers of Genitourinary Cancers

  2022cites this paper
• The role of diffusion-weighted imaging on 3 tesla magnetic resonance in the clinical staging and pathological grading of clear cell renal carcinoma

  2022cites this paper
• Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma—A Proof of Principle Study

  2022cites this paper
• Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma.

  2022cites this paper
• Prospects of texture analysis in radiological imaging for diagnosis of renal parenchyma tumor

  2022cites this paper
• Nuclear morphometry is a superior prognostic predictor in comparison to histological grading in renal cell carcinoma:A retrospective clinico-pathological study

  2022cites this paper
• Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study

  2022cites this paper
• Systematic review and meta-analysis of multiparametric MRI clear cell likelihood scores for classification of small renal masses

  2022cites this paper
• The Critical Gene Screening to Prevent Chromophobe Cell Renal Carcinoma Metastasis through TCGA and WGCNA

  2022cites this paper
• Differentiation of Clear Cell and Non-clear-cell Renal Cell Carcinoma through CT-based Radiomics Models and Nomogram

  2022cites this paper
• Updated national study of functional graft renal cell carcinomas: are they a different entity?

  2022cites this paper
• Elevated expression of LIF predicts a poor prognosis and promotes cell migration and invasion of clear cell renal cell carcinoma

  2022cites this paper
• Differentiating renal epithelioid angiomyolipoma from clear cell carcinoma: using a radiomics model combined with CT imaging characteristics

  2022cites this paper
• Overexpression of cytoplasmic dynamin 2 is associated with worse outcomes in patients with clear cell renal cell carcinoma

  2022cites this paper
• Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82)

  2022cites this paper
• Multimodality imaging of renal lymphoma and its mimics

  2022cites this paper
• Diagnostic Workup for Patients with Solid Renal Masses: A Cost-Effectiveness Analysis

  2022cites this paper
• A Clinical Radiomics Nomogram Was Developed by Integrating Radiomics Signatures and Clinical Variables to Distinguish High-Grade ccRCC from Type 2 pRCC

  2022cites this paper
• Artificial Intelligence in Kidney Cancer.

  2022cites this paper
• Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers

  2022cites this paper